Edition:
United Kingdom

Nordic Nanovector ASA (NANOV.OL)

NANOV.OL on Oslo Stock Exchange

65.90NOK
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
kr65.90
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
462,279
52-wk High
kr95.05
52-wk Low
kr37.26

Chart for

About

Nordic Nanovector ASA is a Norway-based company active in the biotechnology industry. It is engaged in the development and commercialization of targeted therapeutics for hematological cancers. Its main product candidate is Betalutin, comprising a tumor-seeking anti-CD37 antibody conjugated to a low intensity radionuclide... (more)

Overall

Beta: --
Market Cap(Mil.): kr4,031.45
Shares Outstanding(Mil.): 49.04
Dividend: --
Yield (%): --

Financials

  NANOV.OL Industry Sector
P/E (TTM): -- 82.81 32.74
EPS (TTM): -5.17 -- --
ROI: -33.62 2.00 14.38
ROE: -33.67 3.49 16.08

NORWEGIAN STOCKS-Down on rate outlook, Scatec drops after share issue

OSLO, June 14 (Reuters) - * Norwegian shares traded down on Thursday * Global markets dented by outlook for higher interest rates and weaker data from China * Oslo's benchmark index fell 0.24 pct, or -2.19 points, to 893.81 points and was up by 10.01 pct year-to-date * The broader Oslo All Share Index was down 0.14 percent * Brent crude futures, a trigger for the oil heavy Oslo Bourse, fell $-0.19 to $76.55 a barrel * Among the biggest firms on the Oslo Bourse, Equinor rose 0.28 pct, Telenor fel

14 Jun 2018

BRIEF-Nordic Nanovector Appoints Tone Kvåle As Interim Chief Executive Officer

* NORDIC NANOVECTOR APPOINTS TONE KVÅLE AS INTERIM CHIEF EXECUTIVE OFFICER

20 Apr 2018

BRIEF-Nordic Nanovector Says Humalutin Has Shown Significant Tumour Uptake

* POSTER REPORTING ANTI -TUMOUR EFFECT OF HUMALUTIN® (177LU-CONJUGATED HUMANIZED ANTI-CD37 ANTIBODY, 177LU-NNV003) IN PRECLINICAL MODELS OF NON-HODGKIN'S LYMPHOMA (NHL) WAS PRESENTED YESTERDAY

16 Apr 2018

BRIEF-Nordic Nanovector's ex-CEO bought 10,000 shares

* ‍LUIGI COSTA, WHO RESIGNED AS CEO ON WEDNESDAY, HAS ON APRIL 5 PURCHASED 10,000 SHARES IN NORDIC NANOVECTOR ASA AT AN AVERAGE SHARE PRICE OF NOK 43.56​

05 Apr 2018

Nordic Nanovector hopes to have CEO replacement shortly

April 5 Nordic Nanovector ASA Chairman Ludvik Sandnes told reporters and analysts on Thursday:

05 Apr 2018

BRIEF-Nordic Nanovector's Paradigme faces delay, Humalutin indefinitely postponed

* ‍NORDIC NANOVECTOR PROVIDES UPDATE ON PARADIGME CLINICAL TRIAL​

04 Apr 2018

BRIEF-‍Nordic Nanovector Says Luigi Costa Will Step Down As CEO

* ‍NORDIC NANOVECTOR ANNOUNCES THAT LUIGI COSTA WILL STEP DOWN AS CHIEF EXECUTIVE OFFICER​

04 Apr 2018

BRIEF-Nordic Nanovector Q4 Comprehensive Loss At NOK ‍87.6​ Mln

* Q4 COMPREHENSIVE LOSS NOK ‍87.6​ MILLION VERSUS LOSS NOK 59.3 MILLION YEAR AGO Source text for Eikon: Further company coverage: (Gdynia Newsroom)

27 Feb 2018

Earnings vs. Estimates